Accord

2024 Canadian Car of the Year winners announced by Automobile Journalists Association of Canada

Retrieved on: 
Thursday, February 15, 2024

TORONTO, Feb. 15, 2024 /CNW/ - The four winners of the 2024 Canadian Car of the Year Awards (CCOTY), presented by the Automobile Journalists Association of Canada (AJAC), were announced today during the opening ceremonies of the Canadian International Auto Show.

Key Points: 
  • TORONTO, Feb. 15, 2024 /CNW/ - The four winners of the 2024 Canadian Car of the Year Awards (CCOTY), presented by the Automobile Journalists Association of Canada (AJAC), were announced today during the opening ceremonies of the Canadian International Auto Show.
  • The Toyota Prius is the 2024 Canadian Car of the Year.
  • The 2024 Canadian Utility Vehicle of the Year is the Toyota Grand Highlander.
  • The Genesis Electrified G80 takes home the award as the 2024 Canadian Electric Car of the Year.

Northeastern University and Open 6G OTIC Partners with AT&T and Verizon to Advance Open and Interoperable Cellular Networks in NTIA T&E Award

Retrieved on: 
Wednesday, February 14, 2024

"We are happy to work with leading operators and vendors to advance the Open RAN ecosystem," says Tommaso Melodia, Director of WIoT at Northeastern University.

Key Points: 
  • "We are happy to work with leading operators and vendors to advance the Open RAN ecosystem," says Tommaso Melodia, Director of WIoT at Northeastern University.
  • The Northeastern University Open 6G OTIC is a one-stop shop for Open RAN innovation.
  • It serves as a hub for the development and testing of next-generation wireless networks utilizing Open RAN technology and Artificial Intelligence.
  • The Northeastern University OTIC can also test massive Multiple Input, Multiple Output (MIMO) radios, key to improving the spectral efficiency of Open RAN.

DOCOMO to Collaborate with AT&T, Verizon and Jio for Open RAN Verifications

Retrieved on: 
Tuesday, February 13, 2024

TOKYO, Feb 13, 2024 - (JCN Newswire) - NTT DOCOMO, INC. announced today that it will participate in Open RAN verifications in the United States as the ACCoRD (Acceleration of Compatibility and Commercialization for Open RAN Deployments) project in a consortium jointly founded with AT&T Inc. (AT&T), Verizon Communications Inc. (Verizon), and Reliance Jio Infocomm Ltd. (Jio).

Key Points: 
  • TOKYO, Feb 13, 2024 - (JCN Newswire) - NTT DOCOMO, INC. announced today that it will participate in Open RAN verifications in the United States as the ACCoRD (Acceleration of Compatibility and Commercialization for Open RAN Deployments) project in a consortium jointly founded with AT&T Inc. (AT&T), Verizon Communications Inc. (Verizon), and Reliance Jio Infocomm Ltd. (Jio).
  • This consortium was awarded a USD 42.3 million grant from the U.S. Department of Commerce National Telecommunications and Information Administration (NTIA)(1) on February 12.
  • The consortium comprises telecom operators and US universities and suppliers include equipment vendors from the United States and abroad, and is committed to verifying multi-vendor Open RAN connectivity for further commercial deployments.
  • (2) OREX is an Open RAN service provider launched by DOCOMO in collaboration with multiple global vendors, providing customized Open RAN solutions to address the needs of each customer.

Standard Motor Products' Emission Control Program Expands

Retrieved on: 
Wednesday, February 7, 2024

NEW YORK, Feb. 7, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) is dedicated to expanding its comprehensive Emission Control program. Standard's Emission Control program includes evaporative emission control (EVAP), exhaust gas recirculation (EGR), and positive crankcase ventilation emission control systems. With more than 3,500 part numbers, Standard® offers the most complete program in the industry, with everything needed for a complete repair.

Key Points: 
  • Standard's Emission Control program features more than 3,500 parts, including EVAP, EGR, and positive crankcase ventilation products
    SMP manufactures emission control components in its own North American facilities located in South Carolina, Kansas, and Mexico
    Standard® is committed to expanding its comprehensive emission control program, with new products continually released
    NEW YORK, Feb. 7, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) is dedicated to expanding its comprehensive Emission Control program.
  • Standard's Emission Control program includes evaporative emission control (EVAP), exhaust gas recirculation (EGR), and positive crankcase ventilation emission control systems.
  • Standard® emission components are manufactured in three of SMP's North American facilities in Greenville, South Carolina, Independence, Kansas, and Reynosa, Mexico.
  • All new Standard® Emission Control applications are listed in the catalog found at StandardBrand.com and in electronic catalog providers.

The MolinaCares Accord Invests Over $1 Million to Improve Health Equity Throughout Illinois

Retrieved on: 
Tuesday, January 30, 2024

The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Illinois (“Molina”), is launching the MolinaCares Illinois Health Equity Initiative, investing an initial $1 million in a community-based strategy to improve equity and health outcomes for underserved Illinoisans.

Key Points: 
  • The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Illinois (“Molina”), is launching the MolinaCares Illinois Health Equity Initiative, investing an initial $1 million in a community-based strategy to improve equity and health outcomes for underserved Illinoisans.
  • The homeless rate in Illinois has increased to 9.5 per 10,000 people , up from 8 per 10,000 people in 2019.
  • Molina has adopted a statewide approach to address social determinants of health and improve health equity through partnerships with community-based organizations.
  • Joining the Fowler Bonan Foundation and Heaven’s Kitchen to provide over 300 turkeys and hot Christmas dinners for southern Illinois residents.

Accord Healthcare partners with ITN Business for World Cancer Day to explore how innovative approaches are helping shape the future of cancer care

Retrieved on: 
Sunday, February 4, 2024

The reality is every two minutes someone in the UK is diagnosed with cancer, with 1 in 2 people being diagnosed with some form of cancer during their lifetime[1].

Key Points: 
  • The reality is every two minutes someone in the UK is diagnosed with cancer, with 1 in 2 people being diagnosed with some form of cancer during their lifetime[1].
  • The programme also highlights how Accord has played a leading role in partnership with NHS England and MHRA to repurpose older medicines to help new cohorts of patients.
  • "With so many of us affected by cancer, this has been a really important and poignant programme to be part of.
  • Only through collaboration between cancer experts, industry, academia and patient organizations, can we make real progress toward a world without cancer.

CarGurus Unveils the Best Used Cars for 2024, Preparing Shoppers for the Ideal Time to Buy

Retrieved on: 
Wednesday, January 24, 2024

1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today released its 2024 Best Used Car Awards.

Key Points: 
  • 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today released its 2024 Best Used Car Awards.
  • The awards come in time for shoppers to prepare for the best time to buy a used car in 2024, according to CarGurus research.
  • “Now in its sixth year, the CarGurus Best Used Car Awards aim to help consumers pinpoint their ideal car match with added confidence.”
    A preview of the 2024 CarGurus Best Used Car Award winners include:
    CarGurus 2024 Used Car of the Year: Honda Accord (Tenth Generation).
  • Categories include the best small crossover/SUV, best midsize crossover/SUV, best family car, best city car, best large SUV, best luxury crossover/SUV, best small pickup truck, best large pickup truck, best sports car, and CarGurus Used Car of the Year Award.

EDO Names Most Effective Ads of 2023 Across Auto, CPG, Pharma, Retail, Banking, and More

Retrieved on: 
Thursday, January 25, 2024

EDO , the TV outcomes company, released today the most effective ads of 2023 across English- and Spanish-language media.

Key Points: 
  • EDO , the TV outcomes company, released today the most effective ads of 2023 across English- and Spanish-language media.
  • Automotive (Non-Luxury): GMC, Hummer EV - Try Something Different ft. LeBron James :30 , +592% more effective than the Automotive (Non-Luxury) average.
  • EDO also analyzed the most effective ads that aired across Spanish-language TV (SLTV) in 2023.
  • MOST EFFECTIVE ADS ON SPANISH-LANGUAGE MEDIA, 2023 ( full ranking here )
    Automotive (Non-Luxury): Honda, Accord and CR-V - Hybrid x2 :30 , 93% more effective than the Automotive (Non-Luxury) average.

The MolinaCares Accord Supports Washington Community Organizations to Address Health Disparities

Retrieved on: 
Tuesday, January 23, 2024

The MolinaCares Accord (“MolinaCares”), together with Molina Healthcare of Washington , recently donated $350,000 in grants to further advance programs enhancing health equity.

Key Points: 
  • The MolinaCares Accord (“MolinaCares”), together with Molina Healthcare of Washington , recently donated $350,000 in grants to further advance programs enhancing health equity.
  • Washington state ranks second in the country for most unhoused people per capita, according to data from the U.S. Department of Housing and Urban Development.
  • And food and housing costs continue to rise, often impacting the resources available for many to access health care, particularly those in underserved communities.
  • Organizations that received grants include:

Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 15/02/2023, Status: Withdrawn

Retrieved on: 
Tuesday, January 2, 2024

Overview

Key Points: 
  • Overview
    This marketing authorisation has been revoked by the European Commission in order to implement the judgment of the Court of Justice of 16 March 2023 in Commission and Others v Pharmaceutical Works Polpharma, Cases C-438/21 P to C-440/21 P.
    Dimethyl fumarate Accord : EPAR - Medicine overview
    Product information
    Dimethyl fumarate Accord : EPAR - Product information
    13/12/2023
    This medicine’s product information is available in all official EU languages.
  • Select 'available languages' to access the language you need.
  • Product information documents contain:
    - summary of product characteristics (annex I);
    - manufacturing authorisation holder responsible for batch release (annex IIA);
    - conditions of the marketing authorisation (annex IIB);
    - labelling (annex IIIA);
    - package leaflet (annex IIIB).
  • Dimethyl fumarate Accord : EPAR - All Authorised presentations
    Product details
    - Name of medicine
    - Dimethyl fumarate Accord
    - Active substance
    - dimethyl fumarate
    - International proprietary name (INN) or common name
    - dimethyl fumarate
    - Therapeutic area (MeSH)
    - Multiple Sclerosis, Relapsing-Remitting
    - Multiple Sclerosis
    - Anatomical therapeutic chemical (ATC) code
    - L04AX07
    Pharmacotherapeutic groupImmunosuppressants
    Therapeutic indication
    Dimethyl fumarate Accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (RRMS).